Delivery Order SPE2DB20D3104-SPE2DB25FW0J3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,184.02 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $7,484.21 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 17, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete openly for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,728.46 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $8,416.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30. This is a firm fixed price, competitively awarded contract with a completion date of September 22, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The order will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $8,518.60 and an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,064.08 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30, with an ultimate completion date of May 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0J3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,095.55 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The company serves as a critical vendor for federal medical procurement, with particular focus on supporting the Defense Health Agency and other government healthcare systems through flexible contract mechanisms designed to meet varying medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 9/19/25 |